Jyong Biotech CEO to Speak at Major Global Forum Event

Author: Owen Jenkins Updated: 09-18-2025 08:47 AM

Jyong Biotech's Participation in the Global Business Forum

Jyong Biotech Ltd. (NASDAQ: MENS), a pioneering biotechnology company dedicated to developing innovative plant-derived drugs for urinary system diseases, is making headlines with the news that its Chairwoman and CEO, Fu Feng Kuo, has been invited to speak at the esteemed Global Business Forum.

Key Focus Areas for Discussion

Strategic Engagement with the Global Biotech Community

The upcoming Forum, set to take place at the Taipei International Convention Center, will gather industry leaders from Taiwan and the U.S. to explore how Taiwan's biotech sector can tap into global trends. Fu Feng Kuo will join other notable figures to discuss the crucial theme, "How can Taiwan align its biotech and medical industries with global trends?" This discussion aims at fostering international collaboration — a vital step for Taiwan's biotech innovation trajectory.

Core Themes of the Forum

During the event, influential decision-makers in the U.S. biotech sector will convene with Taiwan's foremost new drug development companies. The discussions will revolve around three essential themes:

Innovative drug technology development
Cross-border clinical collaboration
Strategic capital deployment

The emphasis on these themes highlights the need for concerted efforts in drug development and the importance of leveraging strategic partnerships to enhance biotechnology advancements.

About Jyong Biotech

Founded in 2002 and headquartered in Taiwan, Jyong Biotech represents a commitment to science-driven innovation in the biotechnology field. The company focuses on developing and commercializing differentiated, plant-derived therapies aimed primarily at urinary system diseases, with significant market aspirations in the U.S., EU, and Asia.

Jyong Biotech has established comprehensive capabilities in drug development—encompassing everything from early-stage drug discovery, clinical trials, to regulatory affairs and commercialization. Their flagship product, BOTRESO, alongside other botanical drug candidates, showcases their dedication to addressing unmet medical needs with first-class drugs designed to benefit patients globally.

Further Information and Contact

To learn more about Jyong Biotech's initiatives and research, their official website is a valuable resource.

For investor inquiries, Janice Wang from WFS Investor Relations Inc. can provide additional information.

Contact Details:

Email: services@wealthfsllc.com

Phone: +1 628 283 9214

Frequently Asked Questions

What is Jyong Biotech's main focus?

Jyong Biotech focuses on developing innovative, plant-derived new drugs aimed mainly at treating urinary system diseases.

Who is speaking at the Global Business Forum?

Fu Feng Kuo, the Chairwoman and CEO of Jyong Biotech, will be speaking at the Forum.

What are the key themes of the Forum?

The Forum will focus on innovative drug technology, cross-border clinical collaborations, and strategic capital deployment.

Where will the event be held?

The Global Business Forum will take place at the Taipei International Convention Center.

How to contact Jyong Biotech for more information?

Investors can contact Janice Wang at WFS Investor Relations via email or phone for more details.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.